Page 27 - SFHN817pages36p.qxp_SFHN 0608 Friday 5.0

Mount Sinai Heart New York at

Jupiter Medical Center Announces Accreditation

for Its Cardiac Program

One of Only Two Hospitals in the Region to Receive

an Accreditation for Cardiovascular Excellence

Mount Sinai Heart New York at Jupiter Medical Center announced today that its fellows, nursing personnel, technologists and other personnel, reporting of results, pro-
cardiac program has been fully accredited for cardiac catheterization by cedure indications and informed consent, procedure preparation and conduct, patient
Accreditation for Cardiovascular ExcellenceTM (ACE), an independent, physician- outcomes, quality assurance, and radiation safety.
led organization that evaluates and monitors providers of cardiovascular care. ACE Jupiter Medical Center’s two state-of-the-art cardiac catheterization labs provide an
accreditation is a professional review of an organization’s structure, internal processes, array of services including:
patient safety practices, and clinical outcomes to determine if it meets the nationally- • Balloon Angioplasty
accepted best practice standards established by experts in cardiac and endovascular care. • Thrombectomy
“It is an honor to have our cardiac program receive an accreditation from such an • Stent Implantation
esteemed institution,” said John Couris, President and CEO of Jupiter Medical Center. • Cardiac Biopsy
“This achievement, along with the fact that we recently received state approval to estab- • Coronary & Left Ventricular Digital Angiography
lish an open-heart program, speaks volumes about the commitment of every member of • Diagnostic Cardiac Catheterization
our cardiac team whose hard work ensures we bring the highest quality health care to • Coronary Intravascular Ultrasound
the community.” • Pacemaker & ICD Insertion
Accreditation means that Jupiter Medical Center’s cardiac program maintains the • Right & Left Heart Catheterization
highest standards for cardiovascular and endovascular care, and that the doctors and ACE accreditation is just the latest of several significant steps Jupiter Medical
staff caring for patients undergoing diagnostic and interventional catheterization proce- Center has taken to transform cardiac care in the region. In 2015, Jupiter Medical
dures uphold those same standards. Center and The Mount Sinai Hospital launched a pioneering partnership to enhance
“We congratulate Jupiter Medical Center for seeking and obtaining an ACE cardiac cardiac patient care services and research in South Florida. “Progressive partnerships
catheterization accreditation,” said ACE Chief Medical Officer Bonnie Weiner, M.D. “By like this are an important part of how we consistently deliver world-class health care
submitting to a rigorous, independent evaluation, you have shown an uncompromising to the region,” said Gonzalo Loveday, MD, Medical Director of Mount Sinai Heart
commitment to provide safe, high-quality care.” New York at Jupiter Medical Center. In 2016, the Medical Center completely reno-
To become certified, Jupiter Medical Center demonstrated excellence in the following vated its cardiopulmonary rehabilitation center. In 2018, Jupiter Medical Center will
categories: facility, equipment, leadership structure, physician extenders and cardiology begin offering open-heart surgery.

RCMP, Inc. Announces
Sylvester Comprehensive Cancer
Opening of New Offices
Center Only Site in South Florida
in Coral Gables and Orlando
to Offer New Bladder
Revenue Cycle Management Professionals, Inc. (RCMP) is very proud to
Cancer Detection System announce it has opened its state-of-the-art corporate Headquarters in Coral
Gables. RCMP will be opening a Satellite office in Orlando to serve its Providers
in Central Florida on August 1. RCMP is a Healthcare Management and
Sylvester Comprehensive
Cancer Center, part of the Consulting, Medical Billing and EHR Software Company.
University of Miami Health RCMP is headed by General Partner Juan H. Kouri, MHSA with over 25 years as
System, is the only institution a leader in healthcare management, practice management and Electronic Medical
in South Florida offering Records and General Partner Christopher Roqueta with over 15 years of health-
flourescence enhanced Blue care sales and business development experience.
Light Cystoscopy with Cys - RCMP already has Medical Practice clients in South Florida, Central Florida,
view®, an optical imaging Maine, California and Oklahoma.
agent for the detection of
bladder cancer. Cysview is the
only FDA-approved imaging
Chad R. Ritch, M.D., MBA, urologic oncologist at Sylvester Comprehensive SEND US YOUR
agent for use with photody-
namic diagnosis/fluorescence enhanced cystoscopy.
Cancer Center, has already begun successfully using the technology which
makes hard-to-see tumors that may be present in the bladder more visible,
standing out against normal tissue and making it easier to identify and remove
them.
Traditionally, when a tumor in the bladder is detected, doctors perform a
transurethral resection, a surgical procedure where cancerous tissue is scraped
out of the bladder. White light cystoscopy has been the standard for visualizing
these suspicious lesions during the resection. However, when used on its own, • News Tips
harder-to-see tumors can often be missed, leaving cancerous cells behind
which can result in recurrence or spread of the residual cancer cells deeper • Letters To the Editor
into the bladder. • Announce New Hires
Cysview works by exploiting fluorescent properties of naturally occurring
molecules which are then transformed into liquid and injected into the bladder and Promotions
one hour prior to the cystoscopy to coat its lining. Abnormal cancerous cells
will absorb this molecule making them appear red when exposed to light from • Promote Your Event
a specific wavelength. Physicians are then better able to detect and remove the
red glowing cancer cells in contrast to normal tissue, which appears in blue. • Announce Business-Related Awards
Studies have shown that use of Blue Light Cystoscopy has resulted in a 16 • Tout Your Success
percent increase in detection of bladder tumors and approximately 10 percent
decrease in cancer recurrence. In addition, patients who undergo Blue Light
cystoscopy have a longer time to recurrence compared to those who have tra-
ditional white light cystoscopy. E-mail your submissions to
editorial@
southfloridahospitalnews.com

South Florida Hospital News southfloridahospitalnews.com August 2017 27